Dental Bone and Graft Substitutes Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034

Page: 215 | Report Code: LS250110 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

The dental bone and graft substitutes are referred to the material, including natural and synthetic both, such as allograft, xenografts, etc. They are used in bone regeneration and in dental procedures such as surgeries and implants, proving structural integrity and stability.          

MARKET OVERVIEW 

The market valuation of the dental bone and graft substitutes market was valued at approximately USD xx billion in 2023 and is projected to reach USD xx billion in 2034 exhibiting a CAGR of xx.x% during the forecast period of 2024-2034. The market is aligned with healthcare sector, which makes it a sustainable and growing market.   


GROWTH DRIVERS 

The rise in the incidences of dental disorders is one of the primary and key drivers of the market. As WHO (World Health Organization) states, there is an estimated 2 billion people suffer from caries of permanent teeth and 514 million children suffer from caries of primary teeth, globally. Prevalence of the main oral diseases continues to increase globally with growing urbanization and changes in living conditions.


The rise in the aging population is another significant driver of the market as they highly incident age-related bone deterioration and tooth loss, contributing towards significant growth. The United Nations highlights there is a rise in aging population where it is estimated that by 2050 the global population of 22.0% will be aged 60 years or more. The awareness campaign initiatives such as World Oral Health Day also drives the market towards growth, leading to higher adoption of this techniques.
 
MARKET SEGMENTATION: 

·         By Type- autograft, allograft, alloplast, xenograft, synthetic bone graft and others   

·         By Application- ridge augmentation, sinus lift, periodontal defect regeneration, implant bone regeneration and socket preservation 

·         By Mechanism- Osteoconduction, osteoinduction, osteopromotion and osteogenesis 

·         By End Users- hospitals and clinics   

·         By Regions- North America, Europe, Asia Pacific, South America, Middle East and Africa

Dental Bone and Graft Substitutes Market Segment by Type Review: 

In the autograft, the healthcare professionals uses patients bone tissue for the grafting driven by the no risk of immune rejection. An allograft is a material that is derived from one person and implanted in another person whereas a xenograft is a material derived from any nonhuman animal that is implanted in a human. The synthetic bone graft is referred to the synthetic or artificial material used to replace natural bone tissue.       

           

Regional Analysis: 

North America is a significant market driven by the presence of high prevalence of dental disorders coupled with advanced healthcare sector. Europe is another significant market driven by the rise in aging population and rise in medical tourism, mainly for dental. APAC is significantly growing market driven by rapid rising dental disorders and expanding dental tourism. MEA is a promising market driven by investments in healthcare infrastructure. South America is another growing market driven by growing dental tourism.   


Key Challenges: 

The dental bone and graft substitutes market are highly incident to risk of infection and immune rejection, this may raise concern among patients, hindering the market growth and adoption. Moreover, the market faces competition from alternatives available in the market and it required skilled professionals with expertise in dentistry where lack of skilled personnel may hamper the market growth.

Competitive Landscape: 

In the highly competitive dental bone and graft substitutes market, companies are investing heavily in research and development to innovate and improve their products and services. They are also collaborating, forming strategic partnerships, or acquiring other companies to gain access to new market segments, enhance distribution networks, and increase market share.

The key news and development includes-

·         In April 2023, Henry Schein acquired a majority ownership position in Biotech Dental, aiming to create a digital workflow that provides a seamless journey for customers to increase case acceptance and improve clinical outcomes for practitioners.

·         In March 2022, Dentsply Sirona Inc. partnered with Platform for Better Oral Health in Europe. The goal is to improve oral health and the prevention of oral diseases - as well as address oral health inequalities and challenges.

·         In February 2022, Envista Holdings Corporation (US) partnered with Vitaldent Group (Spain). This extended agreement positions Envista as the preferred supplier of implants (Nobel Biocare) and clear aligners (Spark).

·         In January 2022, Johnson & Johnson partnered with Microsoft Corporation, Inc. The Johnson & Johnson Medical Devices Companies (JJMDC) collaborated with Microsoft Corporation Inc, (US) to enable and expand JJMDC’s secure and compliant digital surgery ecosystem.

·         In February 2024, ZimVie Inc. launched its TSX Implant in Japan, enhancing its dental implant offerings with features designed for immediate extraction and standard loading protocols, aiming to compete in the premium dental implant market.

·         In November 2023, Keystone Dental launched the GENESIS ACTIVE Implant System, a comprehensive dental implant solution featuring innovative technologies designed to enhance implant placement efficiency and aesthetic outcomes.

·         In March 2022, Envista Holdings Corporation re-brands its dental imaging business to DEXIS, encompassing a range of digital imaging solutions and devices like CBCT, handheld X-rays, intraoral scanners, and surgical systems, alongside brands i-CAT, Instrumentarium, SOREDEX, and NOMA. 

Global Key Players:  

·         Dentsply Sirona

·         Biohorizons Inc.

·         Zimmer Biomet

·         Rti Surgicals

·         Medtronic

·         Geistlich Pharma Ag

·         Dentium Co, Ltd.

·         Envista Holdings Corporation

·         Zimvie

·         Keystone Dental

·         Other Players

Attributes

Details

Base Year

2023

Trend Period

2024 – 2034

Forecast Period

2024 – 2034

Pages

215

By Type

Autograft, Allograft, Alloplast, Xenograft, Synthetic Bone Graft And Others

By Application

Ridge Augmentation, Sinus Lift, Periodontal Defect Regeneration, Implant Bone Regeneration And Socket Preservation

By Mechanism

Osteoconduction, Osteoinduction, Osteopromotion And Osteogenesis

By End Users

Hospitals and Clinics

By region

North America, Europe, Asia Pacific, the Middle East and Africa, and South America

Company Profiles

Dentsply Sirona, Biohorizons Inc., Zimmer Biomet, Rti Surgicals, Medtronic, Geistlich Pharma Ag, Dentium Co, Ltd., Envista Holdings Corporation, Zimvie, Keystone Dental, Other Players

Edition

1st edition

Publication

January 2025

Buy Report